1,002
Participants
Start Date
April 21, 2021
Primary Completion Date
November 11, 2022
Study Completion Date
November 11, 2022
Biomarker Data Collection
During this study, a sample of your blood will be collected and you will have a PET scan taken of your brain. Blood sample results will be compared to PET scan pictures to understand how well the markers in the blood predict whether there is amyloid in the brain. Blood samples will also be collected that contain your genes. These genetic samples will also be compared to PET scans to help researchers understand how different people react to medicines and to understand the genetic causes of Alzheimer's disease. Some of the samples will be stored for future analysis.
Velocity Clinical Research - Syracuse, Syracuse
Progressive Medical Research, Port Orange
Charter Research - Lady Lake, Lady Lake
ClinCloud, Maitland
K2, Orlando
Charter Research - Winter Park, Winter Park
Visionary Investigators Network - Pembroke Pines, Pembroke Pines
Visionary Investigators Network - Coral Gables, Coral Gables
Visionary Investigators Network - South Miami, Miami
Visionary Investigators Network - Aventura, Aventura
JEM, Lake Worth
Axiom Clinical Research of Florida, Tampa
Great Lakes Clinical Trials, Chicago
Kansas University Alzheimer's Disease Center (KUADC), Fairway
Kerwin Research Center, Dallas
El Faro Health and Therapeutics, Rio Grande City
Lead Sponsor
GAP Innovations, PBC
INDUSTRY